AUM $204.5MER 0.99%NAV $41.66Holdings 59Inception Aug 2023
Price Chart
Key Statistics
Previous Close
$41.76Day Range
$41.48$42.30
52-Week Range
$26.73$45.24
Avg Volume
22.6KDividend Yield
0.05%Expense Ratio
0.99%AUM
$204.5MShares Outstanding
3.2METF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 79.95% |
| Switzerland | 9.76% |
| United Kingdom | 3.03% |
| Denmark | 2.91% |
| China | 1.92% |
| Other | 1.12% |
| Germany | 0.77% |
| Singapore | 0.55% |
Fund Information
- Issuer
- Tema
- Category
- Healthcare
- Types
- Biotech
- Inception Date
- Aug 14, 2023
- Exchange
- NASDAQ
- Description
- The Tema Oncology ETF (CANC) seeks to invest in companies that potentially stand to benefit from further advances in oncology related biotechnology and healthcare.
Similar ETFs
The Tema Oncology ETF (CANC) is an exchange-traded fund issued by Tema that launched on Aug 14, 2023. It currently manages $204.5M in assets under management. The fund charges an expense ratio of 0.99%. The fund holds 59 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 39.5% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | RVMD | REVOLUTION MEDICINES INC | 5.46% | 54,887 | $11.2M |
| 2 | COGT | COGENT BIOSCIENCES INC | 5.05% | 303,132 | $10.3M |
| 3 | MRK | MERCK & CO INC | 4.64% | 65,538 | $9.5M |
| 4 | LLY | ELI LILLY & CO | 4.45% | 8,097 | $9.1M |
| 5 | NOVN.SW | NOVARTIS AG | 3.56% | 52,786 | $7.3M |
| 6 | BMY | BRISTOL-MYERS SQUIBB CO | 3.54% | 113,617 | $7.2M |
| 7 | ABBV | ABBVIE INC | 3.43% | 27,506 | $7.0M |
| 8 | JNJ | JOHNSON & JOHNSON | 3.22% | 24,705 | $6.6M |
| 9 | ONC | BEONE MEDICINES LTD | 3.14% | 18,783 | $6.4M |
| 10 | RHHBY | ROCHE HOLDING AG | 3.06% | 117,767 | $6.3M |
| 11 | HALO | HALOZYME THERAPEUTICS INC | 3.02% | 57,674 | $6.2M |
| 12 | GMAB | GENMAB A/S | 2.91% | 184,482 | $5.9M |
| 13 | EXEL | EXELIXIS INC | 2.87% | 102,082 | $5.9M |
| 14 | IMNM | IMMUNOME INC | 2.84% | 232,377 | $5.8M |
| 15 | CGON | CG ONCOLOGY INC | 2.75% | 78,021 | $5.6M |
Page 1 of 2
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | -0.37% | |
| 1W | -5.72% | |
| 1M | -2.40% | |
| 3M | +10.83% | |
| 6M | +13.27% | |
| YTD | +20.06% | |
| 1Y | +51.41% | |
| 3Y | +71.33% | |
| 5Y | +65.62% |
Moving Averages
20-Day MA
$43.74
Below 20-Day MA50-Day MA
$42.41
Below 50-Day MA200-Day MA
$38.19
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$45.24
Current Price
$41.61
52-Week Low
$26.73
$26.73$45.24
Current Yield
0.05%
Annual Dividend
$1.6252
Frequency
1x/year
Last Ex-Date
Dec 10, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 10, 2025 | $0.0196 | Dec 11, 2025 |
| Dec 11, 2024 | $0.7283 | Dec 12, 2024 |
| Dec 11, 2024 | $0.7283 | Dec 12, 2024 |
| Dec 13, 2023 | $0.1491 | Dec 15, 2023 |
| Dec 13, 2023 | $0.1491 | Dec 15, 2023 |
Dividend Payments Over Time
Category Comparison
| Metric | CANC | Healthcare(254 ETFs) | Biotech(41 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.99% | 0.62% | 0.85% |
| AUM | $204.5M | $1.73B | $1.80B |
| Dividend Yield | 0.05% | 3.97% | 1.97% |
| Avg Volume | 22.6K | 364.4K | 1.1M |
| Holdings | 59 | 160 | 63 |
| Performance | |||
| 1-Month Return | -2.66% | -2.86% | -0.76% |
| 6-Month Return | +5.14% | +7.23% | +15.71% |
| YTD Return | +19.61% | +10.59% | +18.57% |
| 1-Year Return | — | +8.50% | +16.28% |
Compare with Another ETF
Search for an ETF to compare with CANC:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.